In Vitro Activities of Moxifloxacin and Other Fluoroquinolones against Mycoplasma pneumoniae

A total of 105 isolates of Mycoplasma pneumoniae were evaluated for susceptibility to moxifloxacin, sparfloxacin, levofloxacin, and ciprofloxacin. Moxifloxacin, a newly synthesized compound, showed the greatest activity. The MICs and MBCs at which 50 and 90% of isolates were affected were 0.15 (MIC(...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Hamamoto, Kumiko, Shimizu, Takashi, Fujimoto, Naoyuki, Zhang, Ye, Arai, Sumio
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90571/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11353651/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.6.1908-1910.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!